unaudited financial result for the quarter and half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Checkpoint Trends Limited reported unaudited standalone results for Q2 FY26 with revenue from operations of ₹10,859.42 lakhs, compared to just ₹500 lakhs in Q2 FY25, marking an extraordinary jump. For the half year (H1 FY26), revenue surged to ₹12,030.69 lakhs from ₹1,500 lakhs in H1 FY25, driven mainly by the FMCG segment (₹8,438.59 lakhs) and a new contribution from Tobacco Products (₹3,567.10 lakhs). The company swung to a profit after tax of ₹141.03 lakhs for H1 FY26, against a small loss of ₹0.21 lakhs in H1 FY25, translating to a basic EPS of ₹2.58 for the half year. Total assets ballooned to ₹14,063.95 lakhs (from ₹65.25 lakhs as on March 31, 2025), largely due to a sharp rise in trade receivables (₹13,906.34 lakhs) and matching trade payables (₹13,802.72 lakhs), indicating a working-capital-heavy scaling of operations. The statutory auditor (L K Ajmera & Associates) issued an unqualified/unmodified limited review opinion, and the board approved the results at its meeting on November 12, 2025.
The headline revenue surge and return to profitability are likely to be viewed positively by the market, but investors should note the very thin net margin (~1.2%) and the unusually large trade receivables and payables, which point to a working-capital-intensive business model that could pressure cash flows if collections slow. Overall, the results suggest rapid top-line scaling but profitability and cash conversion remain early-stage.